Cargando…
FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by clonal expansion of myeloid blasts in the bone marrow (BM). Despite advances in therapy, the prognosis for AML patients remains poor, and there is a need to identify novel molecular pathways regulating tumor cell survival and p...
Autores principales: | Dobish, Kasidy K., Wittorf, Karli J., Swenson, Samantha A., Bean, Dalton C., Gavile, Catherine M., Woods, Nicholas T., Ghosal, Gargi, Hyde, R. Katherine, Buckley, Shannon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624613/ https://www.ncbi.nlm.nih.gov/pubmed/37689825 http://dx.doi.org/10.1038/s41375-023-02020-w |
Ejemplares similares
-
Loss of FBXO9 Enhances Proteasome Activity and Promotes Aggressiveness in Acute Myeloid Leukemia
por: Hynes-Smith, R. Willow, et al.
Publicado: (2019) -
Multi-omics reveals mitochondrial metabolism proteins susceptible for drug discovery in AML
por: Caplan, Mika, et al.
Publicado: (2022) -
FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21
por: Zhang, Long, et al.
Publicado: (2019) -
FBXO22 degrades nuclear PTEN to promote tumorigenesis
por: Ge, Meng-Kai, et al.
Publicado: (2020) -
EXM 85-21: 31/10 - 85
por: Malandain, E.
Publicado: (1985)